14 studies found for:    Open Studies | "Thymus Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Thymus Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Sunitinib for Advanced Thymus Cancer Following Earlier Treatment
Conditions: Thymoma;   Thymus Neoplasms
Intervention: Drug: Sunitinib
2 Recruiting Postoperative Conformal Radiotherapy for Stage II-III B Type Thymoma
Condition: Thymoma
Intervention: Radiation: radiotherapy
3 Recruiting Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy
Condition: Malignant Thymoma
Intervention: Drug: Milciclib Maleate
4 Recruiting A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas
Condition: Thymoma
Intervention: Drug: BKM120
5 Recruiting Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma
Conditions: Thymoma;   Thymic Carcinoma.;   Clinical Masaoka Stage II-IVA
Intervention: Drug: Cetuximab, Cisplatin, Doxorubicin & Cyclophosphamide
6 Recruiting Proton Beam Radiation Therapy in Treating Patients With Recurrent Thoracic Cancer Who Have Received Prior Radiation Therapy
Conditions: Lung Metastases;   Recurrent Malignant Mesothelioma;   Recurrent Non-small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer;   Recurrent Thymoma and Thymic Carcinoma
Intervention: Radiation: proton beam radiation therapy
7 Recruiting Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma
Condition: Thymic Carcinoma
Intervention: Drug: Milciclib Maleate
8 Recruiting Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis
Conditions: Lung Cancer;   Non-small Cell Lung Cancer;   Small Cell Lung Cancer;   Pleural Mesothelioma;   Thymoma
Interventions: Drug: Nintedanib;   Drug: Prednisone;   Other: Placebo
9 Recruiting Nonmyeloablative Allogeneic Transplant
Conditions: Aplastic Anemia;   Paroxysmal Nocturnal Hemoglobinuria;   Acute Myelogenous Leukemia;   Acute Lymphocytic Leukemia;   Myelodysplastic Syndrome;   Chronic Myelogenous Leukemia;   Chronic Lymphocytic Leukemia;   Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma;   Mantle Cell Lymphoma;   Multiple Myeloma;   Waldenstrom Macroglobulinemia;   Breast Cancer;   Renal Cell Carcinoma;   Melanoma;   Sarcoma;   Ovarian Cancer;   Thymoma
Intervention: Procedure: Nonmyeloablative Allogeneic Transplant
10 Recruiting Rapid Autopsy and Procurement of Non-Small Cell Lung Cancer Tissue
Conditions: Thymus Tumors;   Mesothelioma;   Non- Small Cell Lung Cancer;   Small Cell Lung Cancer
Intervention:
11 Not yet recruiting MK-3475 in Patients With Thymic Carcinoma
Condition: Thymic Carcinoma
Intervention: Drug: MK-3475
12 Recruiting Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
Conditions: Non-Small Cell Lung Cancer;   Small Cell Lung Cancer;   Extrapulmonary Small Cell Cancer;   Pulmonary Neuroendocrine Tumors;   Thymic Epithelial Tumors
Intervention:
13 Recruiting Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer
Condition: Locally Advanced Stage III or IV Thymic Cancer
Intervention: Drug: neoadjuvant docetaxel/cisplatin
14 Recruiting Cancer Research Repository for Individuals With Cancer Diagnosis and High Risk Individuals.
Conditions: Pancreatic Cancer;   Thyroid Cancer;   Lung Cancer;   Esophageal Cancer;   Thymus Cancer;   Colon Cancer;   Rectal Cancer;   GIST;   Anal Cancer;   Bile Duct Cancer;   Duodenal Cancer;   Gallbladder Cancer;   Gastric Cancer;   Liver Cancer;   Small Intestine Cancer;   Peritoneal Surface Malignancies;   Familial Adenomatous Polyposis;   Lynch Syndrome;   Bladder Cancer;   Kidney Cancer;   Penile Cancer;   Prostate Cancer;   Testicular Cancer;   Ureter Cancer;   Urethral Cancer;   Hypopharyngeal Cancer;   Laryngeal Cancer;   Lip Cancer;   Oral Cavity Cancer;   Nasopharyngeal Cancer;   Oropharyngeal Cancer;   Paranasal Sinus Cancer;   Nasal Cavity Cancer;   Salivary Gland Cancer;   Skin Cancer;   CNS Tumor;   CNS Cancer;   Mesothelioma
Intervention:

Indicates status has not been verified in more than two years